Portuguese distinguished in article about stomach cancerJune 18, 2002Three Portuguese researchers are co-authors of a scientific article about hereditary stomach cancer, published in the medical journal "New England Journal of Medicine" and recently awarded the Benjamin Castleman 2002 Award. Attributed by the International Academy of Pathology, the prize distinguishes the best scientific work in human pathology published in the English language, in the world, during 2001. Under the name of David Huntsman, of the University of British Columbia, in Vancouver (Canada), this article included the participation of F'¡tima Carneiro and Raquel Seruca, members of the teaching staff at the Institute of Molecular Pathology and Immunology of Porto University (Instituto de Patologia e Imunologia Molecular da Universidade do Porto - Ipatimup) and Carlos Caldas of the Department of Oncology of Cambridge University, apart from six other authors. The aforementioned article confirms the recommendation of a total gastrectomy to prevent stomach cancer in carriers of defects in a certain gene, defects inherited from parents. Despite being rare, these hereditary genetic mutations make their carriers extremely susceptible to a certain form of gastric cancer, already discovered in 1998. The existence of defects in the gene responsible for the production of the protein called E-cadherin is part of the cause of the disease, which is located in the cellular membrane and allows the connection between the stomach cells. The result of these mutations is the abnormal production or the absence of the production of the aforementioned protein, which leads, ultimately, to a diffuse type cancer, in which the cancerous cells appear disconnected. It is worth mentioning that this article was done based on the experience of five people that had their stomachs removed, following the recommendation of a group of international doctors, because they were suffering from those hereditary mutations. Careful studies of the stomachs, carried out after their removal, revealed that, despite previous medical exam not having indicated such, small parts of malignant cells already existed in all patients. In conclusion, close vigilance is not enough for the detection of the problem by way of the dissimulated form in which diffuse gastric cancer behaves. Or rather, the malignant cells infiltrate the stomach walls without causing superficial harm to the mucous membrane and go undetected in many biopsies. | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene. International study supports new standard of treatment for women with advanced ovarian cancer Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Researchers Discover New Enzyme in Cancer Growth While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body. Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Plants display 'molecular amnesia' Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Dancing atoms now understood In developing a model to explain the motion of atoms in a magnetic field, scientists have overcome a decades-old obstacle to understanding a key component of magnetic resonance. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||